June 5, 2007 - Siemens Medical Solutions Molecular Imaging division demonstrated three new syngo software packages, TrueD, Circulation and Scenium for improved workflows in radiology, neurology, radiation oncology and general molecular imaging departments.
Siemens showed an enhanced version of its syngo TrueD software designed for the diagnosis, staging and assessment of cancer treatment response. TrueD provides workflow improvements for hybrid imaging systems used to manage patients with cancer and allows users to fuse and compare up to three PET/CT or SPECT/CT studies simultaneously. Using this method to examine anatomical or functional changes as a result of cancer therapy allows physicians to monitor progress over a course of treatment and to possibly make more timely decisions as to the effectiveness of treatment. Patients who lack significant response may be moved to alternative therapies that could be more successful.
If patients have more than two prior studies, users can drop in new comparison studies without disrupting workflow. The software also fuses MRI studies with traditional nuclear medicine studies. TrueD provides workflow through the fusion of gated images acquired on Siemens’ Biograph PET/CT scanners and exporting those images to radiation therapy planning systems.
Siemens also announced that syngo Circulation software is now available to use with its hybrid imaging scanners. The software provides a noninvasive cardiac evaluation in reportedly less than 10 minutes and it will provide even more diagnostic information when conducting nuclear cardiac stress testsItg performs quantitative coronary assessment, left ventricular analysis and it can fuse all of the data into a single report.
syngo Circulation includes segmentation of the coronary artery tree, giving users an angiography-like view. They can also add additional vessel segments with single clicks. The software also has several advanced, 3-D image reconstruction options, such as free-rotating, curved, multiplanar reformatting.
Siemens also showcased syngo Scenium for neurological evaluations with either PET/CT or SPECT/CT imaging. Scenium combines standard anatomy and a comprehensive database of normal brain scans and matches those against newly acquired clinical scans. It automatically correlates the current patient study with an average healthy brain for preliminary abnormality computation. The fusion engine produces results that are reliable and reproducible between multiple sessions and multiple users.
Scenium performs a voxel-by-voxel evaluation of the abnormal regions and automatically identifies anatomical regions of interest, which are optimized for dementia evaluation. It also renders a color-coded statistical analysis that highlights patterns of hyper-metabolism and hypo-metabolism and incorporates these data elements into clinical reports.


Related Content

News | Artificial Intelligence

December 5, 2023 — Pixyl has announced FDA 510(k) clearance for Pixyl.Neuro, the next-generation AI software for brain ...

Time December 05, 2023
arrow
News | Proton Therapy

July 5, 2023 — RaySearch Laboratories AB announced a strategic collaboration agreement with B dot Medical Inc. aimed at ...

Time July 05, 2023
arrow
News | Radiation Therapy

May 30, 2023 — The first treatment, for a patient with prostate cancer, was successfully carried out on April 28. Yonsei ...

Time May 30, 2023
arrow
News | Oncology Information Management Systems (OIMS)

May 24, 2023 — RaySearch Laboratories AB announced that the oncology information system RayCare* (* subject to ...

Time May 24, 2023
arrow
Feature | AIMed | Christine Book

May 10, 2023 — The AiMed Global Summit will be held June 4-7, 2023, in San Diego, Calif, and program details offered ...

Time May 10, 2023
arrow
News | Radiation Oncology

February 20, 2023 — Varian, a Siemens Healthineers company, has entered into an agreement with Nova Scotia Health to ...

Time February 20, 2023
arrow
Feature | Oncology Information Management Systems (OIMS)

August 2, 2022 — The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to ...

Time August 02, 2022
arrow
News | Artificial Intelligence

May 31, 2022 — Patient trust is not a barrier to artificial intelligence (AI) adoption by medical imaging professionals ...

Time May 31, 2022
arrow
News | Radiation Therapy

May 18, 2022 — RaySearch announced that the treatment control system RayCommand is in clinical use at the innovative ...

Time May 18, 2022
arrow
News | Artificial Intelligence

May 17, 2022 — Edgility, Inc. launched EdgeAi as healthcare's first operationally embedded AI with Explainability ...

Time May 17, 2022
arrow
Subscribe Now